Logo image of MBI-H.CA

MANY BRIGHT IDEAS TECHNOLOGI (MBI-H.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:MBI-H - CA5650851077 - Common Stock

0.025 CAD
0 (0%)
Last: 11/19/2025, 7:00:00 PM
Fundamental Rating

1

MBI-H gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 23 industry peers in the Biotechnology industry. MBI-H has a bad profitability rating. Also its financial health evaluation is rather negative. MBI-H has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MBI-H has reported negative net income.
MBI-H had a negative operating cash flow in the past year.
MBI-H had negative earnings in each of the past 5 years.
In multiple years MBI-H reported negative operating cash flow during the last 5 years.
MBI-H.CA Yearly Net Income VS EBIT VS OCF VS FCFMBI-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100K -200K -300K

1.2 Ratios

MBI-H's Return On Assets of -641.46% is on the low side compared to the rest of the industry. MBI-H is outperformed by 82.61% of its industry peers.
Industry RankSector Rank
ROA -641.46%
ROE N/A
ROIC N/A
ROA(3y)-2058.38%
ROA(5y)-1367.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBI-H.CA Yearly ROA, ROE, ROICMBI-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MBI-H so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBI-H.CA Yearly Profit, Operating, Gross MarginsMBI-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

MBI-H has about the same amout of shares outstanding than it did 1 year ago.
MBI-H has more shares outstanding than it did 5 years ago.
MBI-H has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBI-H.CA Yearly Shares OutstandingMBI-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MBI-H.CA Yearly Total Debt VS Total AssetsMBI-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K

2.2 Solvency

Based on the Altman-Z score of -2587.93, we must say that MBI-H is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MBI-H (-2587.93) is worse than 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2587.93
ROIC/WACCN/A
WACCN/A
MBI-H.CA Yearly LT Debt VS Equity VS FCFMBI-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50K -50K -100K -150K

2.3 Liquidity

MBI-H has a Current Ratio of 0.04. This is a bad value and indicates that MBI-H is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.04, MBI-H is not doing good in the industry: 78.26% of the companies in the same industry are doing better.
A Quick Ratio of 0.04 indicates that MBI-H may have some problems paying its short term obligations.
MBI-H has a Quick ratio of 0.04. This is in the lower half of the industry: MBI-H underperforms 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
MBI-H.CA Yearly Current Assets VS Current LiabilitesMBI-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K

More info and screens

1

3. Growth

3.1 Past

MBI-H shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.82%, which is quite good.
EPS 1Y (TTM)8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
MBI-H.CA Price Earnings VS Forward Price EarningsMBI-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBI-H.CA Per share dataMBI-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MBI-H does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MANY BRIGHT IDEAS TECHNOLOGI

TSX-V:MBI-H (11/19/2025, 7:00:00 PM)

0.025

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners22.49%
Ins Owner ChangeN/A
Market Cap381.50K
Revenue(TTM)N/A
Net Income(TTM)-52.60K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -641.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2058.38%
ROA(5y)-1367.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -2587.93
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31700%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31700%
OCF growth 3YN/A
OCF growth 5YN/A

MANY BRIGHT IDEAS TECHNOLOGI / MBI-H.CA FAQ

Can you provide the ChartMill fundamental rating for MANY BRIGHT IDEAS TECHNOLOGI?

ChartMill assigns a fundamental rating of 1 / 10 to MBI-H.CA.


What is the valuation status for MBI-H stock?

ChartMill assigns a valuation rating of 0 / 10 to MANY BRIGHT IDEAS TECHNOLOGI (MBI-H.CA). This can be considered as Overvalued.


How profitable is MANY BRIGHT IDEAS TECHNOLOGI (MBI-H.CA) stock?

MANY BRIGHT IDEAS TECHNOLOGI (MBI-H.CA) has a profitability rating of 0 / 10.